ACCUiN α/β Thalassemia Screening Kit is a qualitative test designed using polymerase chain reaction (PCR) technology. Specific regions of the human HBA1, HBA2, and HBB genes are amplified, followed by capillary electrophoresis and Sanger sequencing to determine the variation status. ACCUiN α/β Thalassemia Screening Kit can be used to detect whether the test sample contains single nucleotide variants (SNVs), multi-nucleotide variants (MNVs), insertions, deletions, or insertion/deletion (INDEL) variants in the human HBA1 (NM_000558), HBA2 (NM_000517), and HBB (NM_000518) genes.

ACCUiN α/β Thalassemia Screening Kit has undergone quality validation and functional verification to ensure performance stability and reproducibility. ACCUiN α/β Thalassemia Screening Kit accommodates at least 48 testing reactions.